Breaking News Instant updates and real-time market news.

ATRA

Atara Biotherapeutics

$15.61

0.86 (5.83%)

09:38
09/11/19
09/11
09:38
09/11/19
09:38

Atara Biotherapeutics management to meet with Cowen

Meeting to be held in Europe on September 11 hosted by Cowen.

  • 11

    Sep

ATRA Atara Biotherapeutics
$15.61

0.86 (5.83%)

06/04/19
SBSH
06/04/19
UPGRADE
Target $24
SBSH
Neutral
Atara Biotherapeutics upgraded to Neutral from Sell at Citi
Citi analyst Yigal Nochomovitz last night upgraded Atara Biotherapeutics to Neutral from Sell and raised his price target for the shares to $24 from $23. The analyst says his Sell thesis has played out and that Atara's valuation now better reflects the "niche" target populations for lead program tab-cel in EBVPTLD.
06/05/19
MZHO
06/05/19
NO CHANGE
Target $62
MZHO
Buy
FDA seems to like Atara's Tab-cel, trial size 'too aggressive,' says Mizuho
Mizuho analyst Salim Syed notes that Atara Biotherapeutics provided partial outcomes of the regulatory discussions it has been having with the FDA on its two ongoing Phase 3 Tab-cel PTLD trials. After talking to management, the analyst says that the news seems to suggest that the FDA likes Tab-cel for PTLD and wants to get it to approval, but is dealing with the reality that this a rare, very sick patient population and the previous trial design requiring about 105 patients may have been "a bit too aggressive." The news also raises several unanswered questions, he adds. Syed has a Buy rating and $62 price target on the shares.
07/01/19
ADAM
07/01/19
NO CHANGE
Target $70
ADAM
Buy
Canaccord maintains $70 price target on Atara after 'clean' safety data
Atara Biotherapeutics reported that 18 patients received ATA-188 at three different dose levels without dose limiting toxicity or adverse events leading to discontinuation, which bodes well for Phase 2, Canaccord Genuity analyst John Newman tells investors in a research note. The analyst maintains a Buy rating on the shares with a $70 price target as he awaits efficacy for ATA-188 in the second half of 2019. He views the safety data in multiple sclerosis as "clean."
07/16/19
ROTH
07/16/19
NO CHANGE
Target $30
ROTH
Buy
Atara delayed timing of regulatory authority submissions, says Roth Capital
Atara Biotherapeutics announced this morning an update to its development plan for the open-label phase III "Tab-cel" program in patients with Epstein Barr virus associated post-transplant proliferative disease. The update is a slight change to what had been expected and creates a delay in timing of regulatory authority submissions, Roth Capital analyst Tony Butler tells investors in a research note. The biologics license application filing in the U.S. will be in the second half of 2020, and will be before the submission in Europe. The analyst had expected the opposite. Further, he believes the timing of the EU submission is now unclear. Butler, however, reiterates a Buy rating on Atara Biotherapeutics with a $30 price target. The stock in morning trading is down 11% to $16.10.

TODAY'S FREE FLY STORIES

OSTK

Overstock.com

$16.19

-1.41 (-8.01%)

09:03
09/19/19
09/19
09:03
09/19/19
09:03
Hot Stocks
Overstock.com down 9.3% in pre-market after founder Byrne sold 4.7M share stake »

Shares of Overstock.com…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

MNKD

MannKind

$1.33

-0.055 (-3.97%)

09:03
09/19/19
09/19
09:03
09/19/19
09:03
Hot Stocks
MannKind presents data from one-year study of Afrezza Inhalation Powder »

MannKind announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 02

    Oct

NAV

Navistar

$29.09

-0.08 (-0.27%)

09:02
09/19/19
09/19
09:02
09/19/19
09:02
Hot Stocks
Navistar to build new manufacturing facility in Texas »

Navistar announced it…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

AJG

Arthur J. Gallagher

$89.89

0.26 (0.29%)

09:00
09/19/19
09/19
09:00
09/19/19
09:00
Hot Stocks
Arthur J. Gallagher acquires Andrew Insurance Associates »

Arthur J. Gallagher…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

09:00
09/19/19
09/19
09:00
09/19/19
09:00
General news
Fed's overnight repo was oversubscribed again »

Fed's overnight repo…

HOOK

Hookipa Pharma

$8.03

0.22 (2.82%)

08:59
09/19/19
09/19
08:59
09/19/19
08:59
Hot Stocks
Hookipa Pharma to present data on TheraT technology at CICON Conference »

HOOKIPA Pharma will…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 27

    Sep

VBIV

VBI Vaccines

$0.67

-0.0482 (-6.68%)

08:58
09/19/19
09/19
08:58
09/19/19
08:58
Syndicate
VBI Vaccines 70M share Secondary priced at 50c »

Raymond James and…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

CNC

Centene

$46.02

0.475 (1.04%)

, WCG

WellCare

$268.55

1.17 (0.44%)

08:57
09/19/19
09/19
08:57
09/19/19
08:57
Hot Stocks
Centene, WellCare announce state insurance department approvals for merger »

Centene (CNC) and…

CNC

Centene

$46.02

0.475 (1.04%)

WCG

WellCare

$268.55

1.17 (0.44%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

  • 27

    Sep

  • 02

    Oct

  • 22

    Oct

  • 25

    Oct

  • 28

    Oct

  • 29

    Oct

  • 30

    Oct

  • 31

    Oct

GIII

G-III Apparel

$24.78

0.03 (0.12%)

08:56
09/19/19
09/19
08:56
09/19/19
08:56
Recommendations
G-III Apparel analyst commentary  »

G-III one of the…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 25

    Sep

08:56
09/19/19
09/19
08:56
09/19/19
08:56
Conference/Events
The Federal Energy Regulatory Commission (FERC) to hold a meeting »

Open Commission Meeting…

T

AT&T

$36.77

-0.39 (-1.05%)

, FDX

FedEx

$150.91

-22.62 (-13.04%)

08:55
09/19/19
09/19
08:55
09/19/19
08:55
Options
Notable open interest changes for September 19th »

Wednesday's total…

T

AT&T

$36.77

-0.39 (-1.05%)

FDX

FedEx

$150.91

-22.62 (-13.04%)

BAC

Bank of America

$30.00

0.08 (0.27%)

ROKU

Roku

$129.79

-20.64 (-13.72%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 20

    Sep

  • 23

    Sep

  • 30

    Sep

  • 01

    Oct

  • 16

    Oct

  • 23

    Oct

  • 13

    Nov

  • 17

    Dec

08:55
09/19/19
09/19
08:55
09/19/19
08:55
Conference/Events
Morgan Stanley global autos analysts to hold an analyst/industry conference call »

European Autos &…

IHRT

iHeartMedia

$14.79

0.11 (0.75%)

08:53
09/19/19
09/19
08:53
09/19/19
08:53
Initiation
iHeartMedia initiated  »

B. Riley FBR starts…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 19

    Sep

  • 23

    Sep

PODD

Insulet

$148.04

3 (2.07%)

08:50
09/19/19
09/19
08:50
09/19/19
08:50
Conference/Events
Insulet participates in a conference call with SVB Leerink »

Conference call with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

BMWYY

BMW

$0.00

(0.00%)

08:50
09/19/19
09/19
08:50
09/19/19
08:50
Periodicals
BMW to cut up to 6,000 jobs in Germany, Bloomberg reports »

BMW plans to cut up to…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

08:50
09/19/19
09/19
08:50
09/19/19
08:50
General news
The 2k initial claims uptick to 208k »

The 2k initial claims…

08:50
09/19/19
09/19
08:50
09/19/19
08:50
General news
U.S. Q2 current account balance narrowed to -$128.2 B »

U.S. Q2 current account…

PPC

Pilgrim's Pride

$30.86

-0.39 (-1.25%)

08:49
09/19/19
09/19
08:49
09/19/19
08:49
Recommendations
Pilgrim's Pride analyst commentary  »

Pilgrim's Pride…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 13

    Nov

GIS

General Mills

$54.51

-0.52 (-0.94%)

08:48
09/19/19
09/19
08:48
09/19/19
08:48
Recommendations
General Mills analyst commentary  »

Operating gains at…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 01

    Oct

NEOG

Neogen

$78.05

-0.71 (-0.90%)

08:48
09/19/19
09/19
08:48
09/19/19
08:48
Hot Stocks
Neogen partners with IGS to enhance Igenity Beef Profile »

Neogen has entered into a…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 24

    Sep

  • 03

    Oct

  • 13

    Nov

PRSP

Perspecta

$26.02

0.015 (0.06%)

08:47
09/19/19
09/19
08:47
09/19/19
08:47
Hot Stocks
Perspecta Labs awarded $2.9M contract from CMG »

Perspecta announced that…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

INSP

Inspire Medical

$64.41

0.14 (0.22%)

08:46
09/19/19
09/19
08:46
09/19/19
08:46
Conference/Events
Inspire Medical participates in a conference call with SVB Leerink »

Conference call with…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

EWW

iShares MSCI Mexico

$43.37

-0.4 (-0.91%)

, CGC

Canopy Growth

$28.82

0.42 (1.48%)

08:45
09/19/19
09/19
08:45
09/19/19
08:45
Options
Largest borrow rate increases among liquid names »

Latest data shows the…

EWW

iShares MSCI Mexico

$43.37

-0.4 (-0.91%)

CGC

Canopy Growth

$28.82

0.42 (1.48%)

FSLY

Fastly

$28.53

0.285 (1.01%)

INSG

Inseego

$4.98

0.04 (0.81%)

PAYS

Paysign

$10.67

-0.57 (-5.07%)

PD

PagerDuty

$30.41

-0.125 (-0.41%)

UBER

Uber

$34.24

-0.04 (-0.12%)

TELL

Tellurian

$8.34

0.01 (0.12%)

UPRO

Uproar Inc

$57.03

0.055 (0.10%)

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

  • 25

    Sep

  • 26

    Sep

08:45
09/19/19
09/19
08:45
09/19/19
08:45
General news
U.S. Philly Fed index fell 4.8 points to 12.0 in September »

U.S. Philly Fed index…

RAMP

LiveRamp

$46.01

-0.4 (-0.86%)

08:44
09/19/19
09/19
08:44
09/19/19
08:44
Recommendations
LiveRamp analyst commentary  »

LiveRamp conference…

03/08/13
Wedge Partners
03/08/13
Credit Suisse
03/06/13
Citigroup
03/06/13
Barclays

See Street Research during your Free Trial

Get Full Fly Access

Breaking market intelligence sent straight to you
Our team of experts analyze every news story and filter out the noise to deliver real-time market moving news.
Up-to-date information on important industry events
Get real-time updates on events that are moving the market—from conferences and calls to syndicate announcements.
News focused on the companies in your portfolio
Create up to 12 portfolios with 150 stocks each, and see how active they are in market news.